A facile method for isolation of recombinant human apolipoprotein A-I from E. coli
Abstract
Apolipoprotein (apo) A-I is the major protein component of high-density lipoprotein (HDL) and plays key roles in the Reverse Cholesterol Transport pathway. In the past decade, reconstituted HDL (rHDL) has been employed as a therapeutic agent for treatment of atherosclerosis. The ability of rHDL to promote cholesterol efflux from peripheral cells has been documented to reduce the size of atherosclerotic plaque lesions. However, development of apoA-I rHDL-based therapeutics for human use requires a cost effective process to generate an apoA-I product that meets “Good Manufacturing Practice” standards. Methods available for production and isolation of unmodified recombinant human apoA-I at scale are cumbersome, laborious and complex. To overcome this obstacle, a streamlined two-step procedure has been devised for isolation of recombinant untagged human apoA-I from E. coli that takes advantage of its ability to re-fold to a native conformation following denaturation. Heat treatment of a sonicated E. coli supernatant fraction induced precipitation of a large proportion of host cell proteins (HCP), yielding apoA-I as the major soluble protein. Reversed-phase HPLC of this material permitted recovery of apoA-I largely free of HCP and endotoxin. In conclusion, purified apoA-I possessed α-helix secondary structure, formed rHDL upon incubation with phospholipid and efficiently promoted cholesterol efflux frommore »
- Authors:
-
- Children's Hospital Oakland Research Inst., Oakland CA (United States)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Foundry
- California State Univ. (CalState), Long Beach, CA (United States). Dept. of Chemistry and Biochemistry
- McGill Univ. Health Centre, Montreal, QC (Canada). Research Inst.
- Publication Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH)
- OSTI Identifier:
- 1379871
- Alternate Identifier(s):
- OSTI ID: 1416242
- Grant/Contract Number:
- AC02-05CH11231; T32 DK061918; R37 HL-64159
- Resource Type:
- Journal Article: Accepted Manuscript
- Journal Name:
- Protein Expression and Purification
- Additional Journal Information:
- Journal Volume: 134; Journal Issue: C; Journal ID: ISSN 1046-5928
- Publisher:
- Elsevier
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; Apolipoprotein A-I; High density lipoprotein; Thermal denaturation; Cholesterol efflux; Circular dichroism; E. coli; Reversed phase HPLC
Citation Formats
Ikon, Nikita, Shearer, Jennifer, Liu, Jianfang, Tran, Jesse J., Feng, ShiBo, Kamei, Ayako, Beckstead, Jennifer A., Kiss, Robert S., Weers, Paul M., Ren, Gang, and Ryan, Robert O. A facile method for isolation of recombinant human apolipoprotein A-I from E. coli. United States: N. p., 2017.
Web. doi:10.1016/j.pep.2017.03.015.
Ikon, Nikita, Shearer, Jennifer, Liu, Jianfang, Tran, Jesse J., Feng, ShiBo, Kamei, Ayako, Beckstead, Jennifer A., Kiss, Robert S., Weers, Paul M., Ren, Gang, & Ryan, Robert O. A facile method for isolation of recombinant human apolipoprotein A-I from E. coli. United States. https://doi.org/10.1016/j.pep.2017.03.015
Ikon, Nikita, Shearer, Jennifer, Liu, Jianfang, Tran, Jesse J., Feng, ShiBo, Kamei, Ayako, Beckstead, Jennifer A., Kiss, Robert S., Weers, Paul M., Ren, Gang, and Ryan, Robert O. 2017.
"A facile method for isolation of recombinant human apolipoprotein A-I from E. coli". United States. https://doi.org/10.1016/j.pep.2017.03.015. https://www.osti.gov/servlets/purl/1379871.
@article{osti_1379871,
title = {A facile method for isolation of recombinant human apolipoprotein A-I from E. coli},
author = {Ikon, Nikita and Shearer, Jennifer and Liu, Jianfang and Tran, Jesse J. and Feng, ShiBo and Kamei, Ayako and Beckstead, Jennifer A. and Kiss, Robert S. and Weers, Paul M. and Ren, Gang and Ryan, Robert O.},
abstractNote = {Apolipoprotein (apo) A-I is the major protein component of high-density lipoprotein (HDL) and plays key roles in the Reverse Cholesterol Transport pathway. In the past decade, reconstituted HDL (rHDL) has been employed as a therapeutic agent for treatment of atherosclerosis. The ability of rHDL to promote cholesterol efflux from peripheral cells has been documented to reduce the size of atherosclerotic plaque lesions. However, development of apoA-I rHDL-based therapeutics for human use requires a cost effective process to generate an apoA-I product that meets “Good Manufacturing Practice” standards. Methods available for production and isolation of unmodified recombinant human apoA-I at scale are cumbersome, laborious and complex. To overcome this obstacle, a streamlined two-step procedure has been devised for isolation of recombinant untagged human apoA-I from E. coli that takes advantage of its ability to re-fold to a native conformation following denaturation. Heat treatment of a sonicated E. coli supernatant fraction induced precipitation of a large proportion of host cell proteins (HCP), yielding apoA-I as the major soluble protein. Reversed-phase HPLC of this material permitted recovery of apoA-I largely free of HCP and endotoxin. In conclusion, purified apoA-I possessed α-helix secondary structure, formed rHDL upon incubation with phospholipid and efficiently promoted cholesterol efflux from cholesterol loaded J774 macrophages.},
doi = {10.1016/j.pep.2017.03.015},
url = {https://www.osti.gov/biblio/1379871},
journal = {Protein Expression and Purification},
issn = {1046-5928},
number = C,
volume = 134,
place = {United States},
year = {Mon Mar 20 00:00:00 EDT 2017},
month = {Mon Mar 20 00:00:00 EDT 2017}
}
Web of Science
Works referenced in this record:
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial
journal, November 2003
- Nissen, Steven E.; Tsunoda, Taro; Tuzcu, E. Murat
- JAMA, Vol. 290, Issue 17
Protective Effects of HDL Against Ischemia/Reperfusion Injury
journal, January 2016
- Gomaraschi, Monica; Calabresi, Laura; Franceschini, Guido
- Frontiers in Pharmacology, Vol. 7
Nanodisks: hydrophobic drug delivery vehicles
journal, March 2008
- Ryan, Robert O.
- Expert Opinion on Drug Delivery, Vol. 5, Issue 3
Cationic lipid nanodisks as an siRNA delivery vehicle
journal, June 2014
- Ghosh, Mistuni; Ren, Gang; Simonsen, Jens B.
- Biochemistry and Cell Biology, Vol. 92, Issue 3
HDL as a contrast agent for medical imaging
journal, August 2009
- Cormode, David P.; Frias, Juan C.; Ma, Yanqing
- Clinical Lipidology, Vol. 4, Issue 4
Bacterial expression and characterization of mature apolipoprotein A-I
journal, July 2002
- Panagotopulos, Stacey E.; Witting, Scott R.; Horace, Erica M.
- Protein Expression and Purification, Vol. 25, Issue 2
Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease
journal, July 2009
- Tubb, Matthew R.; Smith, Loren E.; Davidson, W. Sean
- Journal of Lipid Research, Vol. 50, Issue 7
Integrated solution to purification challenges in the manufacture of a soluble recombinant protein in E. coli
journal, February 2010
- Caparon, Maire H.; Rust, Kevin J.; Hunter, Alan K.
- Biotechnology and Bioengineering, Vol. 105, Issue 2
Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virus
journal, May 2001
- Dagouassat, Nathalie; Haeuw, Jean-François; Robillard, Virginie
- Journal of Immunological Methods, Vol. 251, Issue 1-2
Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state.
journal, April 1996
- Gursky, O.; Atkinson, D.
- Proceedings of the National Academy of Sciences, Vol. 93, Issue 7
Thermal Unfolding of Apolipoprotein A-1. Evaluation of Methods and Models
journal, May 2015
- Schulthess, Therese; Schönfeld, Hans-Joachim; Seelig, Joachim
- Biochemistry, Vol. 54, Issue 19
Differences in Stability among the Human Apolipoprotein E Isoforms Determined by the Amino-Terminal Domain †
journal, September 2000
- Morrow, Julie A.; Segall, Mark L.; Lund-Katz, Sissel
- Biochemistry, Vol. 39, Issue 38
An optimized negative-staining protocol of electron microscopy for apoE4•POPC lipoprotein
journal, November 2009
- Zhang, Lei; Song, James; Newhouse, Yvonne
- Journal of Lipid Research, Vol. 51, Issue 5
Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy
journal, October 2010
- Zhang, Lei; Song, James; Cavigiolio, Giorgio
- Journal of Lipid Research, Vol. 52, Issue 1
EMAN: Semiautomated Software for High-Resolution Single-Particle Reconstructions
journal, December 1999
- Ludtke, Steven J.; Baldwin, Philip R.; Chiu, Wah
- Journal of Structural Biology, Vol. 128, Issue 1
SPIDER and WEB: Processing and Visualization of Images in 3D Electron Microscopy and Related Fields
journal, January 1996
- Frank, Joachim; Radermacher, Michael; Penczek, Pawel
- Journal of Structural Biology, Vol. 116, Issue 1
FREALIGN: High-resolution refinement of single particle structures
journal, January 2007
- Grigorieff, Nikolaus
- Journal of Structural Biology, Vol. 157, Issue 1
Nanobiotechnology applications of reconstituted high density lipoprotein
journal, January 2010
- Ryan, Robert O.
- Journal of Nanobiotechnology, Vol. 8, Issue 1
Therapeutic applications of reconstituted HDL: When structure meets function
journal, January 2016
- Darabi, Maryam; Guillas-Baudouin, Isabelle; Le Goff, Wilfried
- Pharmacology & Therapeutics, Vol. 157
A gel-based method for purification of apolipoprotein A-I from small volumes of plasma
journal, November 2010
- Brace, Rachel J.; Sorrenson, Brie; Sviridov, Dmitri
- Journal of Lipid Research, Vol. 51, Issue 11
Isolation and characterization of apolipoproteins A-I, A-II, and A-IV
book, January 1986
- Bryan Brewer, H.; Ronan, Rosemary; Meng, Martha
- Methods in Enzymology
High yield and secretion of recombinant human apolipoprotein AI in Pichia pastoris
journal, April 2006
- Feng, Mei-qing; Cai, Qin-sheng; Song, Da-xin
- Protein Expression and Purification, Vol. 46, Issue 2
High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression
journal, March 1996
- Sorci-Thomas, M. G.; Parks, J. S.; Kearns, M. W.
- Journal of Lipid Research, Vol. 37, Issue 3
Production of Mature Human Apolipoprotein A-I in a Baculovirus–Insect Cell System: Propeptide Is Not Essential for Intracellular Processing but May Assist Rapid Secretion
journal, November 1997
- Pyle, Louise E.; Fidge, Noel H.; Barton, Peter A.
- Analytical Biochemistry, Vol. 253, Issue 2
A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I
journal, May 2001
- Safi, Wael; Maiorano, J. Nicholas; Davidson, W. Sean
- Journal of Lipid Research, Vol. 42, Issue 5
Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipoprotein A-I in solution.
journal, June 1980
- Edelstein, C.; Scanu, A. M.
- Journal of Biological Chemistry, Vol. 255, Issue 12
Endotoxin removal and prevention for pre-clinical biologics production
journal, November 2012
- Serdakowski London, Anne; Kerins, Brendan; Tschantz, William R.
- Biotechnology Journal, Vol. 7, Issue 12
Works referencing / citing this record:
High-efficient bacterial production of human ApoA-I amyloidogenic variants: Recombinant Human ApoA-I Amyloidogenic Variants
journal, November 2018
- Del Giudice, Rita; Lagerstedt, Jens O.
- Protein Science, Vol. 27, Issue 12
Single-Molecule 3D Images of “Hole-Hole” IgG1 Homodimers by Individual-Particle Electron Tomography
journal, June 2019
- Lei, Dongsheng; Liu, Jianfang; Liu, Hongbin
- Scientific Reports, Vol. 9, Issue 1
Single-Molecule 3D Images of “Hole-Hole” IgG1 Homodimers by Individual-Particle Electron Tomography
journal, June 2019
- Lei, Dongsheng; Liu, Jianfang; Liu, Hongbin
- Scientific Reports, Vol. 9, Issue 1